GlassScriptPhysician profile
Richard A Dickstein
NPI 1376595108
$876.05
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $862 · 2024: $14.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $251.79 | 2019 | |
| Amgen INC. | $153.76 | 2019 | |
| Amarin Pharma, INC. | $86.68 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $67.23 | 2019 | |
| Boston Scientific Corporation | $59.79 | 2019 | |
| Sanofi-Aventis U.S. LLC | $52.22 | 2019 | |
| Janssen Pharmaceuticals, INC | $38.59 | 2019 | |
| Pfizer INC. | $37.91 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $27.64 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $14.53 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.60 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.18 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.99 | 2019 | |
| Angiodynamics, INC. | $11.98 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.92 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $11.28 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $10.96 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Dickstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.